| Mepha Pharma AG - Sacubitril-Valsartan-Mepha 97 mg/103 mg, Filmtabletten | | 69813 | | 03 | | Sacubitril-Valsartan-Mepha 97 mg/103 mg | | Filmtabletten | | C09DX04 | | Valsartan and Sacubitril | | 11.12.2025 | | |
| | Composition | | Filmtablette: sacubitrilum 97.20 mg ut sacubitrilum natricum, valsartanum 102.80 mg ut valsartanum dinatricum, cellulosum microcristallinum, talcum, hydroxypropylcellulosum substitutum humile, crospovidonum, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 4000, E 171, E 172 (rubrum), E 172 (nigrum), pro compresso obducto corresp. natrium 16.284 mg. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. | informations additionels |
|---|
| Sacubitrilum | 97.2 mg | Filmtablette | | Valsartan | 102.8 mg | |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum Substitutum Humile | | | | Hypromellosum | | Überzug | | Macrogol | 4000 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 56 | | | | | Oui | | 006 | 168 | | | | | Oui |
|
|
